Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
43
IRD Quote, Financials, Valuation and Earnings
Last price:
$1.16
Seasonality move
:
-10.47%
Day range:
$1.08 - $1.13
52-week range:
$0.65 - $2.18
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.38x
P/B ratio:
13.17x
Volume:
138.5K
Avg. volume:
687.3K
1-year change:
-42.27%
Market cap:
$66.8M
Revenue:
$11M
EPS (TTM):
-$2.10
Earnings Data
Next earnings date for IRD
Aug 13
2025
Most recent earnings per share
-$0.24
Missed by $0.24
(May 15/2025)
Consensus Estimate
--
(May 15/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IRD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $4.3M | -- | -- | -$0.26 | -- |
| 08/13/2025 | Q2 | $4.3M | -- | -- | -$0.26 | -- |
| 05/15/2025 | Q1 | $3.3M | $4.4M | -$0.24 | -- | -- |
| 03/31/2025 | Q4 | $3.4M | $4.3M | -$1.27 | -$0.34 | -$0.93 |
| 11/12/2024 | Q3 | $2.3M | $3.9M | -$0.29 | -$0.23 | -$0.06 |
| 08/13/2024 | Q2 | $1.9M | $1.1M | -$0.30 | -$0.29 | -$0.02 |
| 03/31/2024 | Q1 | $4.7M | $1.7M | -$0.29 | -$0.14 | -$0.15 |
| 12/31/2023 | Q4 | $6M | $1.7M | -$0.21 | -$0.05 | -$0.16 |
| 09/30/2023 | Q3 | -- | -- | $0.25 | -$0.23 | $0.48 |
| 06/30/2023 | Q2 | -- | -- | -$0.24 | -$0.24 | -$0.00 |
| 03/31/2023 | Q1 | -- | -- | -$0.28 | -$0.15 | -$0.13 |
| 12/31/2022 | Q4 | -- | -- | $1.58 | $1.01 | $0.58 |
| 09/30/2022 | Q3 | -- | -- | -$0.22 | -$0.29 | $0.07 |
| 06/30/2022 | Q2 | -- | -- | -$0.25 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.35 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.35 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.25 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.52 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$3.57 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$1.72 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.18 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.23 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.44 | -- | -- |
Opus Genetics Earnings Questions
-
How Much did Opus Genetics Generate in Revenue Last Quarter?
Opus Genetics reported $4.4M worth of top line sales in its most recent quarter.
-
Did Opus Genetics Beat Earnings Last Quarter?
Opus Genetics announced earnings per share of -$0.24 which represents a miss of analyst forecast a -- per share.
-
Is Opus Genetics Profitable?
Opus Genetics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Opus Genetics EPS Next Year?
Opus Genetics's earnings are forecast to decrease from -$2.15 per share to -$1.22 per share next year representing a decrease of -49.3%.
-
When is Opus Genetics's Earnings Date?
Opus Genetics's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
